F.L. Putnam Investment Management’s Kazia Therapeutics KZIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.84M Buy
414,958
+272,489
+191% +$3.32M 0.07% 187
2026
Q1
$1.06M Buy
+142,469
New +$992K 0.02% 314

Other funds holding KZIA

F.L. Putnam Investment Management's KZIA Position: Q2 2026 in Review

F.L. Putnam Investment Management increased its Kazia Therapeutics (KZIA) stake by 191% in Q2 2026, buying an estimated $3.32M and bringing the position to 414,958 shares worth $5.84M. The position accounts for 0.07% of the portfolio, ranked #187.

F.L. Putnam Investment Management first reported a position in KZIA in Q1 2026 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • F.L. Putnam Investment Management held 414,958 shares of Kazia Therapeutics worth $5.84M as of Q2 2026.
  • F.L. Putnam Investment Management bought 272,489 Kazia Therapeutics shares in Q2 2026, an estimated $3.32M.
  • Kazia Therapeutics made up 0.07% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #187 holding.
  • F.L. Putnam Investment Management first reported a position in Kazia Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 6 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.